Utilizing NIPT in a maternal-fetal medicine practice: Dr. Martin Chavez

May 17, 2018

Dr. Martin Chavez, Chief of Maternal Fetal Medicine at Winthrop University Hospital discusses why he recommends noninvasive prenatal testing (NIPT). He notes that its accuracy, sensitivity, and specificity are incredible compared to what has historically been available. He concludes that NIPT provides both physicians and patients with the confidence and early results they need.

Subscribe to the Illumina video channel

A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Illumina technology is responsible for generating more than 90% of the world’s sequencing data.* Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond. *Data calculations on file. Illumina, Inc., 2017.

View customer spotlight videos 

View Illumina webinars 

View Illumina product videos 

View Illumina support videos 

Share this article on